BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4175985)

  • 1. [Microtechnic for demonstration of the lupus erythematosus phenomenon. Comparison of various technics with our own highly sensitive technic].
    Beickert A; Döge H; Döge B; Dobenecker H; Frank U
    Z Gesamte Inn Med; 1968 Jul; 23(13):396-9. PubMed ID: 4175985
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the LE factor].
    Bencze G
    Med Monatsschr; 1969 Nov; 23(11):494-7. PubMed ID: 4190096
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitroblue tetrazolium dye reduction by peripheral leukocytes from rheumatoid arthritis and systemic lupus erythematosus patients measured by a histochemical and spectrophotometric method.
    Wenger ME; Bole GG
    J Lab Clin Med; 1973 Sep; 82(3):513-21. PubMed ID: 4728296
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immuno-fluorescent method in study of lupus erythematosus].
    Rodshteĭn OA; Zubzhitskiĭ IuN
    Ter Arkh; 1968 Aug; 40(8):56-60. PubMed ID: 4194898
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced glucose oxidation by leukocytes incubated with sera from patients with rheumatoid arthritis and systemic lupus erythematosus (SLE).
    Skosey JL; Sorensen LB
    J Lab Clin Med; 1971 Dec; 78(6):977. PubMed ID: 5131860
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamics of the patient's proteinogram in rheumatoid arthritis and systemic lupus erythematosus as affected by hemosorption therapy].
    Dmitriev AA; Shevchenko OP; Petrunin DD
    Ter Arkh; 1984; 56(5):81-4. PubMed ID: 6463893
    [No Abstract]   [Full Text] [Related]  

  • 7. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
    Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
    Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The level of serum thymic activity in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Ternovoĭ KS; Selezneva TN; Gandzha IM; Babynina LIa; Skorik AIu; Ermekova VM
    Ter Arkh; 1993; 65(8):66-7. PubMed ID: 8211807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and systemic lupus erythematosus.
    Gaitonde S; Samols D; Kushner I
    Arthritis Rheum; 2008 Dec; 59(12):1814-20. PubMed ID: 19035410
    [No Abstract]   [Full Text] [Related]  

  • 10. [Von Willebrand factor in plasma of patients with rheumatoid arthritis and lupus erythematosus].
    Paczuski R; Iwan-Zietek I; Kotschy M; Bielawska J; Sadkiewicz S
    Pol Merkur Lekarski; 1998 May; 4(23):254-6. PubMed ID: 9825655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
    Vogt B; Führnrohr B; Müller R; Sheriff A
    Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
    Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid P-component levels in rheumatoid arthritis.
    Levo Y; Ehrenfeld M; Wollner S
    Isr J Med Sci; 1982 Jun; 18(6):715-7. PubMed ID: 7107210
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
    Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA
    J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
    Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technics used for demonstration of the L.E. phenomenon].
    MARMONT A
    Riv Emoter Immunoematol; 1956; 3(2):155-61. PubMed ID: 13390560
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal serum proteins as aids in diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
    BARTON EM
    Med Clin North Am; 1959 Mar; 43(2):607-13. PubMed ID: 13643141
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating tumor necrosis factor alpha in rheumatoid arthritis.
    Borzì RM; Arfilli L; Focherini MC; Pulsatelli L; Meliconi R
    Boll Soc Ital Biol Sper; 1993 Jan; 69(1):39-43. PubMed ID: 8329189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance and mechanism of P-phenomenon].
    Mairose UB; Wolf E; Tolk J; Földi K
    Z Rheumaforsch; 1971; 30(1):34-9. PubMed ID: 5123098
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activities of some lysosomal enzymes of human white blood cells in rheumatoid arthritis, lupus erythematosus and ankylosing spondylitis].
    Fidelski R; Tchórzewski H; Niedworok J
    Acta Haematol Pol; 1971; 2(3):229-34. PubMed ID: 5161837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.